Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A sleep/wake circuit controls isoflurane sensitivity in Drosophila.

Current biology : CB·2013
Same author

Study of the impact of uterine artery embolization (UAE) on endometrial microvessel density (MVD) and angiogenesis.

Cardiovascular and interventional radiology·2013
Same author

Comparative proteomic analysis reveals differentially expressed proteins correlated with fuzz fiber initiation in diploid cotton (Gossypium arboreum L.).

Journal of proteomics·2013
Same author

Sodium intake from various time frames and incident hypertension among Chinese adults.

Epidemiology (Cambridge, Mass.)·2013
Same author

Spatial multi-scale variability of soil nutrients in relation to environmental factors in a typical agricultural region, eastern China.

The Science of the total environment·2013
Same author

Cleavage of metal-ion-induced DNAzymes released from nanolabels for highly sensitive and specific immunoassay.

Bioconjugate chemistry·2013

Related Experiment Video

Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.5K

PepQueryMHC: rapid and comprehensive tumor antigen prioritization from immunopeptidomics data.

Seunghyuk Choi1,2,3, Bing Zhang4,5

  • 1Lester and Sue Smith Breast Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA.

Genome Biology
|December 24, 2025
PubMed
Summary

Identifying tumor-specific peptides is key for cancer immunotherapy. PepQueryMHC is a new, fast tool that helps prioritize tumor antigens from RNA-seq data, improving immunotherapy development.

Keywords:
ImmunoinformaticsImmunopeptidomeMajor histocompatibility complexProteogenomicsTumor antigens

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.0K
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

14.8K

Related Experiment Videos

Last Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.5K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.0K
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

14.8K

Area of Science:

  • Immunology
  • Bioinformatics
  • Oncology

Background:

  • Accurate identification of tumor-specific peptides presented by Major Histocompatibility Complex (MHC) molecules is essential for developing effective cancer immunotherapies.
  • Current methods face challenges in analyzing MHC class II peptides and sequences not found in reference databases.

Purpose of the Study:

  • To introduce PepQueryMHC, an ultra-fast computational tool designed for efficient tumor antigen prioritization.
  • To enhance the analysis of MHC-bound peptides by integrating peptide sequences with translated RNA-sequencing (RNA-seq) reads.

Main Methods:

  • Development and application of PepQueryMHC, a novel bioinformatics tool.
  • Integration of MHC-bound peptide data with translated RNA-seq reads.
  • Validation of the tool's performance in antigen prioritization and peptide origin mapping.

Main Results:

  • PepQueryMHC demonstrates high efficiency in prioritizing both MHC class I and class II tumor antigens.
  • The tool successfully maps the cellular origins of presented peptides.
  • PepQueryMHC helps resolve questions regarding the occurrence of proteasome-spliced peptides in cancer.

Conclusions:

  • PepQueryMHC offers a versatile and rapid solution for tumor antigen discovery in cancer immunotherapy research.
  • The tool advances the ability to analyze complex peptide repertoires, including MHC class II and non-reference sequences.
  • This work facilitates the development of more targeted and effective cancer immunotherapies.